Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEDA: Aspirin for Renal Disease Progression in Type 2 Diabetes
NCT02895113Phase 3Unknown
- Sponsor
- Sapienza University of Rome
- Start
- Jan 2017
- Primary completion
- Jan 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of aspirin in type 2 diabetes mellitus (T2DM), sponsored by Sapienza University of Rome. Status: unknown.
02
Drugs
aspirin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02895113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02895113.